Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Albendazole Plus Ivermectin Against Onchocerciasis
NCT03238131Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albendazole in onchocerciasis, sponsored by University Hospitals Cleveland Medical Center. Started Apr 2012; status: completed.
02
Drugs
albendazole
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT03238131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238131.